LEO Pharma Inc. is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology. LEO Pharma products have been available in the U.S. since 1994, and the company opened the U.S. affiliate in January 2010. The company’s U.S. offices are located in Madison, N.J.

LEO Pharma:

• Has a 100+ year history as a specialty pharmaceutical company, committed to the discovery and development of novel drugs for patients.
• Markets products in 100+ countries worldwide.
• Employs 6,000 dedicated colleagues operating across 61 countries.
• Remains wholly owned by The LEO Foundation and is headquartered in Ballerup, Denmark, outside Copenhagen.

Learn more about our products by visiting our websites:

Enstilar® (calcipotriene and betamethasone dipropionate) Foam, 0.005%/0.064%
Enstilar® Foam Website

Finacea® (azelaic acid) Foam, 15%
Finacea® Foam HCP Website